A world-first clinical experiment published in JAMA could give a simple approach to preserve tens of thousands of units of blood in Canada and much more globally each year. The experiment, which included almost 27,000 patients in 25 adult critical care units (ICUs) throughout Canada, found that utilizing “small-volume” tubes for lab tests reduced the requirement for nearly one blood transfusion for every ten patients.
Most hospitals use standard tubes that extract four to six milliliters (ml) of blood automatically, but a normal laboratory test requires less than 0.5 ml of blood, therefore the rest (more than 90%) is lost. Small-volume tubes on the market contain a weaker vacuum inside that automatically pulls up half as much blood.
While the amount of blood drawn per tube is relatively small, ICU patients typically require multiple blood samples taken multiple times every day. This can add up to significant blood loss that contributes to anemia, or low red blood cells. ICU patients are unable to produce more red blood cells to correct for this blood loss and often require treatment with a blood transfusion.”
Dr. Deborah Siegal, senior author, scientist and hematologist at The Ottawa Hospital who led the trial, which was coordinated, sponsored and funded by the Population Health Research Institute (PHRI) in Hamilton, a joint institute of McMaster University and Hamilton Health Sciences
“This trial showed that we can save one blood transfusion for every 10 ICU patients by simply switching to small-volume tubes for blood collection,” said Dr. Siegal, who maintains appointments with McMaster University and PHRI, in addition to the University of Ottawa. “At a time when everyone is trying to find ways to make health care more sustainable, and preserve our supply of blood products, this study provides a simple solution that can be implemented without additional cost or negative effects. The patients in our study received over 36,000 blood transfusions. With small-volume tubes we may have saved about 1,500 units of blood.”
In Canada, the public health system covers the expenses of blood transfusions ($450 per unit of blood, with additional costs to hospitals for testing, preparation, storage, and so on). Blood donors are not compensated, and blood conservation is a top priority due to frequent shortages.
The study also has crucial consequences for patients, as low red blood cell counts (anemia) can cause fatigue and weakness, as well as other issues including lengthier hospital admissions. While blood transfusions can usually cure anemia, there are some unusual adverse effects to consider, such as trouble breathing, allergic reactions, and infections.
The trial used a unique design in which various ICUs were randomly assigned to utilize either small-volume blood collection tubes or conventional tubes for varying durations of time before switching to the other tubes. The researchers utilized electronic medical records to track how many blood transfusions each patient had, eliminating patients who stayed in the ICU for less than 48 hours.
While prior observational studies have supported the use of small-volume tubes, this is the first clinical experiment to put them through rigorous testing in a hospital setting. The experiment found that, in addition to reducing anemia and the need for blood transfusions, the decreased volume of blood did not interfere with laboratory testing. When the researchers omitted results from the pandemic’s peak (five months of data), the patterns remained consistent but did not reach statistical significance.
For more information: Small-Volume Blood Collection Tubes to Reduce Red Blood Cell Transfusion in the Intensive Care Unit: A Randomized Clinical
more recommended stories
Air Pollution Hurts Brain Health in Just 4 HoursAir Pollution Blurs the Mind, Impairs.
New therapies developed by Oxford experts offer online support for anxiety and post-traumatic stress disordersUrgent treatment solutions are needed for.
three key pillars to tackle antimicrobial resistance effectively — University of Oxford, Medical Sciences DivisionThe High-Level Meeting on antimicrobial resistance.
Oxford Vaccine Group marks 30 years battling ‘deadly six’ diseases with major art installation — University of Oxford, Medical Sciences DivisionThe installation was commissioned to mark.
Professor Ahmed Awarded Funding To Create World’s First Ovarian Cancer Prevention Vaccine — University of Oxford, Medical Sciences DivisionScientists at the University of Oxford,.
New research network unites Oxford University’s global fight against antimicrobial resistance — University of Oxford, Medical Sciences DivisionAntimicrobial resistance (AMR) threatens the foundation.
Typhoid vaccine trial confirms sustained protection for older children — University of Oxford, Medical Sciences DivisionThe TyVOID study, published in the Lancet, measured the.
Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer — University of Oxford, Medical Sciences DivisionThe research addresses the long-recognized poor.
Four Oxford researchers win prestigious Philip Leverhulme Prizes — University of Oxford, Medical Sciences DivisionOnly 30 prizes are awarded throughout.
Kavli Oxford’s Nick Gatford Wins Image of Distinction Award in Nikon Small World Competition — University of Oxford, Medical Sciences DivisionThe Nikon Small World competition, often.
Leave a Comment